Current Primary Outcome Measures •Number of participants that receive 2 doses of dexamethasone per protocol. [ Time Frame: Intervention: 72 hours; Follow-up: 30 days ] -- A total of N=30 recruited ...

RSV testing among infants has increased since 2015, with significant growth post-COVID-19, yet outpatient testing remains low. The study analyzed 20,752 bronchiolitis encounters across four healthcare ...

Nirsevimab continued to provide strong protection against respiratory syncytial virus-associated bronchiolitis in paediatric ...

Evidence-based reviews suggest limited use of diagnostic testing and treatment modalities in the management of bronchiolitis. Although most studies have shown a lack of efficacy for the use of ...

Immunisation with nirsevimab reduced bronchiolitis-related hospitalisations among infants younger than 3 months who visited the emergency department (ED), according to a new study. Nirsevimab also ...

Babies discharged from the emergency department (ED) for bronchiolitis saw mixed benefits from enhanced nasal suctioning, a randomized trial found. Additional resource use -- a composite of ...

The growing role of pediatric intensive care units (PICUs) for managing bronchiolitis in infants and young toddlers over the last decade was associated with increased use of noninvasive respiratory ...

Doctors say a new antibody treatment and maternal vaccine could reduce RSV-related hospitalizations in infants.

RSV is the leading cause of infant hospitalization in the U.S.• Health officials urge vaccination for pregnant women, seniors ...

Background Bronchiolitis and its outcomes have strong socioeconomic determinants. In Liverpool, a city with high deprivation ...

The mainstays of treatment are ensuring adequate rest, hydration, and oxygenation. A humidifier can be used to help loosen sticky mucus. The decision to admit a child to the hospital is made on the ...